News
The Food and Drug Administration on Tuesday approved Johnson & Johnson's nasal spray to be used alone in adults with a major depressive disorder.
The announcement was welcome news for those with major depressive disorder, which affects an estimated 8.3% of the adult population.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results